THERABRON THERAPEUTICS INC has a total of 26 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are DEFREES SHAWN, EFRANAT LTD and CLARASSANCE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | Israel | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Mexico | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | Australia | 1 | |
#10 | Hungary | 1 | |
#11 | Japan | 1 | |
#12 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Fermentation | |
#4 | Therapeutic chemical compounds | |
#5 | Microorganisms | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Winn Melissa E | 15 |
#2 | Pilon Aprile L | 15 |
#3 | Zehmer John K | 8 |
#4 | Hariprakasha Humcha K | 7 |
#5 | Clayton Richard S | 7 |
#6 | Pilon-Clayton Aprile L | 5 |
#7 | Aprile L Pilon | 2 |
#8 | Clayton-Pilon Aprile L | 1 |
#9 | Borgeat Pierre Ph D | 1 |
#10 | Flamand Louis Ph D | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016205430A1 | Recombinant human cc10 protein facilitates repair and protects against damage to the respiratory epithelium due to exposure to both cigarette and other smoke | |
WO2016133560A1 | Recombinant human cc10 protein for treatment of influenza and ebola | |
HUE030838T2 | Recombinant human cc10 protein for treatment of influenza |